Klassen Preston
Regulus Therapeutics Inc. · President & Head of R & D
Klassen Preston is listed in public filings as director, officer: President & Head of R & D. This Klassen Preston insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Regulus Therapeutics Inc. (RGLS). Investors use Klassen Preston's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0528k shares | OtherJun 25, 2025 | $1.1M528k shares | $2.01 | -- | |
| $0675k shares | OtherJun 25, 2025 | $675.0K675k shares | $1.00 | -- | |
| $0350k shares | OtherJun 25, 2025 | $511.0K350k shares | $1.46 | -- | |
| $0225k shares | OtherJun 25, 2025 | $306.0K225k shares | $1.36 | -- | |
| --115.6k shares | OtherJun 25, 2025 | Disclosure amount unavailable115.6k shares | -- | -- | |
| $0120k shares | OtherJun 25, 2025 | $156.0K120k shares | $1.30 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $384k48.1k shares | BuyJun 3, 2025 | $95.9K12k shares | $7.99 | -- | |
| $675k675k shares | Grant / ExerciseJan 30, 2025 | $675.0K675k shares | $1.00 | -- | |
| $46k36.1k shares | SellJan 13, 2025 | $39.7K31.4k shares | $1.26 | -- | |
| $51k37.5k shares | Grant / ExerciseJan 9, 2025 | $51.0K37.5k shares | $1.36 | -- | |
| $88k67.5k shares | Grant / ExerciseJan 9, 2025 | $39.0K30k shares | $1.30 | -- |